Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

At a CAGR of 6.48%, Global Respiratory Drugs Market 2016-2020, Market Research and Forecast Report

The report provides a basic overview of the "Global Respiratory Drugs Market 2016-2020" including definitions, classifications,Growth,Trends.
MarketsandMarkets™ | 09.09.2016

Global Respiratory Drugs Market 2016-2020 Size and Share Published in 2016-05-04 Available for US$ 2500 at Researchmoz.us

Description

About Respiratory Ailments


Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases. Intranasal corticosteroids, antihistamines, immunosuppressants, bronchodilators, and leukotriene antagonists are the respiratory medicines that are commonly used for the treatment of mild-to-moderate respiratory diseases. However, the choice of drug depends on the type and severity of the disease.

Technavios analysts forecast the global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020.

Covered in this report


The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=717638

Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AstraZeneca

Boehringer Ingelheim

F.Hoffman La-Roche

GlaxoSmithKline

Merck

Novartis

Other prominent vendors

Abbott

Actavis

Afferent Pharmaceuticals

Alere

Almirall

Amgen

AptarGroup

Astellas

Aurobindo

Axis Shield

Baxter

Bayer

Biogen

Biotest

Bristol-Myers Squibb

Chiesi Farmaceutici

Cipla

Cytos

Dainippon Sumitomo

Dr. Reddy's Laboratories

FibroGen

Gilead Sciences

Glenmark

GNI Group Ltd

Horizon Pharma

ImmuneWorks

MediciNova

MedImmune

Mylan

Ono Pharmaceutical

Orchid Chemicals and Pharmaceuticals

Perrigo

Pfizer

Promedior

Prometheus

ProMetic Life Sciences

Ranbaxy

Rottapharm Madaus

Sanofi

Shionogi

Siemens Healthcare Diagnostics

Skyepharma

Sosei

Sunovion

Takeda Pharmaceutical

Teva

Theravance

United Therapeutics

Vectura

Vertex

Zai Lab

Market driver

Rise in prevalence of respiratory diseases

For a full, detailed list, view our report

Market challenge

Unknown etiology of asthma and idiopathic pulmonary fibrosis

For a full, detailed list, view our report

Market trend

Use of biologics

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=717638

Table of Content


PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview: Respiratory diseases

Asthma

COPD

Allergic rhinitis

Pulmonary hypertension

Cystic fibrosis

IPF

US FDA-approved respiratory drugs

Browse All Metabolic Disorders Market Research Reports at: http://www.researchmoz.us/metabolic-disorders-market-reports-14.html

About ResearchMoz


ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
[email protected]
http://www.researchmoz.us/




Img of MarketsandMarkets™
About the tenderer: MarketsandMarkets™

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports.